| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $624,131 ) |
| 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 1/22/2025 | NON-COMPETING CONTINUATION | $624,131 |
| 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 2 | 4/21/2025 | SUPPLEMENT FOR EXPANSION | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $781,716 ) |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 2 | 2/21/2024 | SUPPLEMENT FOR EXPANSION | $100,392 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 11/21/2023 | SUPPLEMENT FOR EXPANSION | $32,609 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 2 | 5/24/2024 | NON-COMPETING CONTINUATION | $64,871 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 2 | 2/5/2024 | NON-COMPETING CONTINUATION | $583,844 |
|
 | Issue Date FY: 2023 ( Subtotal = $643,435 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 1/30/2023 | NEW | $643,435 |
|
|